-+ 0.00%
-+ 0.00%
-+ 0.00%

2026 ESMO LBA | INNOVENT ANNOUNCES INTERNATIONAL PHASE 3 STUDY OF ARCOTATUG TAVATECAN (CLDN18.2-ADC) IN GASTRIC CANCER MET DUAL PRIMARY ENDPOINTS OF PFS AND OS

路透·10/23/2026 10:10:01

請登錄查看新聞詳情